<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347820</id>
  <title nil="true"/>
  <common-name>Methyl 4-[[4-[[5-chloro-1-(morpholin-4-ylmethyl)-2-oxoindol-3-ylidene]amino]benzoyl]amino]benzoate</common-name>
  <description>Methyl 4-[[4-[[5-chloro-1-(morpholin-4-ylmethyl)-2-oxoindol-3-ylidene]amino]benzoyl]amino]benzoate is a chemical compound with the formula C28H25ClN4O5. With an average molecular weight of 533.00 g/mol, Methyl 4-[[4-[[5-chloro-1-(morpholin-4-ylmethyl)-2-oxoindol-3-ylidene]amino]benzoyl]amino]benzoate is a heavy molecule.</description>
  <cas>84496-12-8</cas>
  <pubchem-id>55271</pubchem-id>
  <chemical-formula>C28H25ClN4O5</chemical-formula>
  <weight>533</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:38:48Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:38:48Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC(=O)C1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)N=C3C4=C(C=CC(=C4)Cl)N(C3=O)CN5CCOCC5</moldb-smiles>
  <moldb-formula>C28H25ClN4O5</moldb-formula>
  <moldb-inchi>InChI=1S/C28H25ClN4O5/c1-37-28(36)19-4-9-22(10-5-19)31-26(34)18-2-7-21(8-3-18)30-25-23-16-20(29)6-11-24(23)33(27(25)35)17-32-12-14-38-15-13-32/h2-11,16H,12-15,17H2,1H3,(H,31,34)</moldb-inchi>
  <moldb-inchikey>ZGCAPVPOSIBHEN-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">532.1513476</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343713</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>Methyl 4-[[4-[[5-chloro-1-(morpholin-4-ylmethyl)-2-oxoindol-3-ylidene]amino]benzoyl]amino]benzoate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Anilides</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298157</sync-id>
  <structure-inchikey>ZGCAPVPOSIBHEN-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000000000000040008400000100200080000000000000000000400020000000008000000000000000000000000000000002002000001000000000400000080002000000000020800000000100000004000000000000000000010080000050000002110000002000020100020000000000000000001000000040000400000000000000000080000000408004000000000000000000000100000000000000000000084000040020000040000000008000000000000000000040000000000000000000000000401010004000100000000200000000011000008000000042000040000000001400000000000000200100000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKgAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:23Z</structure-indexed-at>
</compound>
